semaglutide alzheimer's clinical trial GLP-1 drugs failed to slow in two big trials David Standaert, M.D., Ph.D., was

Clinical Trial Results The most recent head-to-head study showed tirzepatide provided 47% greater relative weight loss compared to semaglutide

These side effects are usually temporary as your body adjusts, but they can be frustrating

Save your money and put it toward protein and a ferritin check

So far, GLP-1 injections have been the most effective option for weight loss

When medication is appropriate, the discussion should include: The limited evidence for GLP-1 agonists specifically in BED FDA-approved alternatives, including lisdexamfetamine Realistic expectations about outcomes and timeline Potential side effects and monitoring requirements Cost considerations and insurance coverage The importance of combining medication with behavioral interventions Monitoring during treatment should be systematic and multifaceted

For that reason, backup contraception, such as condoms, is often recommended for a period after starting tirzepatide and after each dose increase